Company / Free Cash Flow
Bio-Techne Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$256.6M
FY2025
5-year range
$153.5M / $307.9M
FY2021-FY2025
Trend
+8.7%
vs FY2024
Sector context
#56 of 151
Health Care
What the data says
At $257M, Bio-Techne's free cash flow ranks #56 of 151 in the Health Care sector. Free Cash Flow has fluctuated over the past 10 years, ranging from $127M in FY2016 to $308M in FY2023.
Based on SEC 10-K filings.
$257M in FY2025 with a 5-year CAGR of +10.8%.
Declined from $308M to $257M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +18.7%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
#56 of 151 in Health CareTop 37% of 151This company $256.6M Sector average $779.8M
▼
-67.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.8%, indicating consistent growth.
- In FY2025, free cash flow increased 8.7% year-over-year.
- Ranks #56 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $256.6M | +8.7% |
| FY2024 | $236.1M | -23.3% |
| FY2023 | $307.9M | +100.6% |
| FY2022 | $153.5M | -1.8% |
| FY2021 | $156.2M | +1.8% |
| FY2020 | $153.5M | -1.8% |
| FY2019 | $156.2M | +4.5% |
| FY2018 | $149.4M | +16.3% |
| FY2017 | $128.5M | +1.0% |
| FY2016 | $127.3M | +6.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026